You’re about to leave Bugcrowd

You are seeing this page because you’re being redirected to: https://news7.asia/news/eisai-antiepileptic-drug-fycompa-injection-formulation-approved-in-japan/

Bugcrowd does not endorse or certify the content of external websites. The page may be unsafe.

You can close this tab or window if you don’t want to proceed.